BioElectronics Corp

OTC:BIEL

BioElectronics Corp. engages in the development of wearable, nueromodulation devices for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications. The company is headquartered in Frederick, Maryland. The company went IPO on 2004-04-12. The firm is engaged in the development and manufacturing of non-invasive electroceuticals medical devices. The company manufactures disposable, drug-free, therapy devices: ActiPatch Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints and RecoveryRx devices for chronic and post-operative pain. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and others. The RecoveryRx medical device provides pain management therapy for medical professionals. RecoveryRx uses pulsed electromagnetic therapy to reduce pain and inflammation resulting in accelerated patient recovery and comfort.